We recently compiled a list of the Billionaire Ken Fisher’s Top 10 High Growth Stock Picks. In this article, we are going to ...

Booming sales of its blockbuster incretin-based weight loss and diabetes drugs Mounjaro and Zepbound powered Eli Lilly (LLY) to a 45% jump in ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

Eli Lilly's profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Listen back above. The most effective weight-loss drug on the international market will soon be available in Ireland. Mounjaro (tirzepatide) functions in a similar way to Ozempic, but studies have ...

Goldberg said the company "melded" a CBS News Sunday Mornings appearance from her to sell “bad weight loss drugs." ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...

A charity boss who struggled for years to shed pounds despite having undergone surgery has hailed weight-loss jabs as life ... Wegovy and Mounjaro are taken regularly and work by making you ...

Marketed as a natural alternative to the prescription weight loss medication Mounjaro, the drink is popular online as it contains just four common kitchen ingredients, making it easy for anyone to ...

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.